We are live on
!
Find out more
TCMG
TSP Capital Management Group Portfolio holdings
AUM
$418M
1-Year Est. Return
68.45%
This Fund
S&P 500
This Quarter
Est. Return
-1.26%
1 Year Est. Return
+68.45%
3 Year Est. Return
+177.76%
5 Year Est. Return
+247.33%
10 Year Est. Return
+1,387.97%
AUM
$215M
AUM Growth
-$3.44M
(-1.6%)
Cap. Flow
+$222M
Cap. Flow
% of AUM
103.21%
Top 10 Holdings %
Top 10 Hldgs %
43.51%
Holding
79
New
79
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Celldex Therapeutics
CLDX
|
+$21.5M |
| 2 |
DD
Du Pont De Nemours E I
DD
|
+$9.8M |
| 3 |
MENT
Mentor Graphics Corp
MENT
|
+$9.55M |
| 4 |
SE
Spectra Energy Corp Wi
SE
|
+$9.18M |
| 5 |
Xylem
XYL
|
+$8.46M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.03% |
| 2 | Materials | 12.14% |
| 3 | Communication Services | 11.47% |
| 4 | Industrials | 8.93% |
| 5 | Utilities | 6.55% |
Similar funds
FFA
WPI
TI
VIS
MCM
PA
PIMC
DBRC
TSP Capital Management Group's Q2 2015 Portfolio in Review
As of Q2 2015, TSP Capital Management Group held 79 positions worth $215M, down 1.6% from $218M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
TSP Capital Management Group deployed $222M of net new capital in Q2 2015, opening 79 new positions. Its largest new stake was Celldex Therapeutics: 54,179 shares worth $20.5M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Materials and Communication Services.
- TSP Capital Management Group's largest Q2 2015 buy was Celldex Therapeutics: 54,179 shares worth $20.5M.
- TSP Capital Management Group's ten largest holdings make up 44% of its $215M portfolio in Q2 2015.
- TSP Capital Management Group opened 79 new positions and closed 0 in Q2 2015.
- TSP Capital Management Group's portfolio value fell 1.6% quarter-over-quarter to $215M.
Based on TSP Capital Management Group's 13F filing for Q2 2015, filed 13 Aug 2015.